Track Categories

The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.

  • Track 1-1Club drugs
  • Track 1-2Magic Mushroom
  • Track 1-3Hallucinogens
  • Track 1-4Tuberculosis
  • Track 1-5Prescription drugs and Cold medicines
  • Track 1-6Phencyclidine (PCP)
  • Track 1-7Methadone
  • Track 1-8Psychotherapy
  • Track 1-9Cocaine
  • Track 1-10Tobacco/Nicotine addiction
  • Track 1-11Steroids
  • Track 1-12Heroin,Codeine and Morphine
  • Track 2-1Brain diseases
  • Track 2-2Stress
  • Track 2-3Depression
  • Track 2-4Advances in addiction psychology & psychiatry
  • Track 2-5Mood and anxiety disorder
  • Track 2-6Eating disorders
  • Track 2-7Post Traumatic Stress Disorder and Addiction(PTSD)
  • Track 2-8Addiction Psycology
  • Track 3-1HIV/AIDS
  • Track 3-2Stroke
  • Track 3-3 nervous system disorder
  • Track 3-4Cancer
  • Track 3-5Hepatitis
  • Track 3-6Lung disease
  • Track 3-7Cardiovascular disease
  • Track 3-8Respiratory Disorders
  • Track 4-1Epigenetic mechanisms in Addiction
  • Track 4-2Inherited biological factors contributing to substance abuse and drug addiction
  • Track 4-3Biochemical mechanisms of drug toxicity
  • Track 4-4Genetic linkage studies
  • Track 4-5Biochemical assay for alcoholism
  • Track 4-6Chemical assay of drugs and drug metabolites
  • Track 5-1Adolescent brain
  • Track 5-2Substance-induced delirium
  • Track 5-3Substance-induced persisting dementia
  • Track 5-4Substance-induced persisting amnestic disorder
  • Track 5-5Substance-induced psychotic disorder
  • Track 5-6Substance-induced mood disorder
  • Track 5-7Substance-induced anxiety disorder
  • Track 5-8Hallucinogen persisting perceptual disorder
  • Track 5-9Substance-induced sexual dysfunction
  • Track 5-10Substance-induced sleep disorder
  • Track 5-11Behavioral effects of drug addiction
  • Track 5-12Dysregulation of neural systems
  • Track 5-13Advances in neurobiology of drug addiction
  • Track 5-14Durg use and toxicity
  • Track 5-15Mental and neural effects of misuse
  • Track 6-1Advances in neurology of substance use
  • Track 6-2Substance abuse and alteration in genetic structure
  • Track 6-3Neurological and behavioral changes
  • Track 6-4Substance abuse disorders
  • Track 7-1Fetal Alcohol Syndrome
  • Track 7-2Victimization of sexual assault
  • Track 7-3Breast Cancer
  • Track 7-4Alcoholic hepatitis
  • Track 7-5Osteoporosis
  • Track 7-6Falls and hip fractures
  • Track 7-7Premature menopause
  • Track 7-8Infertility and miscarriages
  • Track 7-9High blood pressure and heart disease
  • Track 7-10Binge drinking
  • Track 7-11Alcoholic rape
  • Track 8-1Social Anxiety Disorder
  • Track 8-2Post-traumatic Stress Disorder (PTSD)
  • Track 8-3Panic Disorder
  • Track 9-1Opium and opioids
  • Track 9-2Seizures and muscle spasms.
  • Track 9-3Opioid intoxication
  • Track 9-4Respiratory depression
  • Track 10-1Electrophysiologic Evidence of Neural Injury or Adaptation
  • Track 10-2Addictive Basis of Marijuana and Cannabinoids
  • Track 10-3Dopamine and Its Modulation of Drug-Induced Neuronal Damage
  • Track 11-1DSM criteria for substance dependence
  • Track 11-2Toxicology tests
  • Track 11-3Forensic toxicology testing 
  • Track 11-4Medical Screening 
  • Track 11-5Employment Drug Testing 
  • Track 11-6Sports/Athletics Screening 
  • Track 11-7Dual diagnosis
  • Track 12-1Advances in epidemiological studies of addiction
  • Track 12-2Social Anxiety and Drug Use
  • Track 12-3Drug Abuse, Dopamine, and the Brain Reward System
  • Track 12-4Behavioral pharmacology research
  • Track 12-5Youth violence and substance abuse
  • Track 12-6Cognitive Improvement and Alcohol Recovery
  • Track 12-7Cocaine Vaccine
  • Track 13-1Neuronopathy
  • Track 13-2Organophosphorus Compounds
  • Track 13-3Solvent-Induced Toxic Encephalopathy
  • Track 13-4Mercury
  • Track 13-5Sensory Functions
  • Track 14-1Alcohol Abuse and Withdrawal
  • Track 14-2Psychiatric Nursing
  • Track 14-3Therapeutic Communication
  • Track 15-1addiction & alcohol treatment
  • Track 15-2Sober living
  • Track 15-3Drug rehabilitation program & centers
  • Track 15-4Neuro rehabilition
  • Track 15-5Drug and alcohol detox
  • Track 16-1Pharmacotherapies
  • Track 16-2Substance abuse treatment
  • Track 16-3Motivational interviewing and incentives
  • Track 16-4Nicotine replacement therapies
  • Track 16-5Bupropion,Varenicline
  • Track 16-6Cognitive Behavioral Therapy
  • Track 16-7Contingency Management
  • Track 16-8Motivational Enhancement Therapy
  • Track 16-9Multidimensional family therapy
  • Track 16-10Rehabilitation house treatment approaches
  • Track 16-11Social behavior and treatment
  • Track 16-12Intervention
  • Track 16-13Maintenance treatment
  • Track 16-14Community reinforcement approach
  • Track 16-15Advances in addiction diagnosis
  • Track 17-1Behavioral counseling.
  • Track 17-2Yoga practice for addictive mind
  • Track 17-3Meditation as a cure for mental health
  • Track 17-4Dance and music therapies